Key result
B.A.S. inhibits nonembolized lung edema in ~88% of dogs, suggesting antiadrenergic rather than antiserotonin mechanisms.
Why the study?
Does the administration of antiserotonins inhibit pulmonary edema in dogs with starch-induced pulmonary embolization?
Does the administration of antiserotonins inhibit pulmonary edema in dogs with starch-induced pulmonary embolization?
The study suggests that pulmonary edema following starch emboli is mediated by sympathetic nervous system reflexes releasing catecholamines and histamine, rather than serotonin.
Answers are grounded in this paper and cite their sources.
Antiserotonin agents show limited efficacy in canine post-embolic edema; leaves open sympathetic reflex mediation for human studies.
A localized pulmonary infarction was produced by injecting a starch suspension into the pulmonary artery wedge position of one lung lobe in pentobarbitalized dogs, and the effect of three so-called antiserotonins on the ensuing pulmonary edema was determined. Edema was inhibited in the nonembolized lung lobes in 88% of the B.A.S. (1-benzyl-2-methyl-5-methoxytryptamine HCl), 45% of the DHE (dihydroergotamine), and 12% of the BOL (2-brom- d-lysergic acid diethylamide) dogs. Reasons are given for assuming that the actions of B.A.S. and DHE are due to their antiadrenergic rather than to any antiserotonin properties which they may have. Serotonin, therefore, at most has a slight role in the pulmonary edema formation caused by starch emboli. It is postulated that the emboli by producing an infarct and setting up a reflex mediated through the sympathetic nervous system, cause the release in turn of catecholamines and of histamine, the latter being immediately responsible for the capillary permeability change leading to pulmonary edema.
No takes yet. Share an insight, caveat, or question.
Kabins et al. (1960) studied Pulmonary embolization and lung edema. Antiserotonins (B.A.S., DHE, BOL) was evaluated on Inhibition of edema in nonembolized lung lobes. Edema in nonembolized lung lobes was inhibited in 88% of dogs treated with B.A.S., 45% with DHE, and 12% with BOL, suggesting antiadrenergic rather than antiserotonin mechanisms.
Synapse has enriched 10 related papers. Consider them for comparative context: